Research & Development
15 July 2025 - Varian, a Siemens Healthineers (ETR:SHL) company, on Tuesday announced the European launch of IntelliBlate, a CE-marked microwave ablation solution for soft tissue tumour treatment.Inte...
15 July 2025 - Clinical-stage biotechnology company Biophytis SA (Euronext Growth Paris:ALBPS) (OTC:BPTSY) revealed on Tuesday that it has entered into a strategic partnership with Lynx Analytics to a...
14 July 2025 - Niagen Bioscience, Inc. (NASDAQ: NAGE), a leader in NAD+ science and healthy aging, on Monday announced the debut of its Tru Niagen supplement and Niagen IV therapy at Equinox Hotel New...
14 July 2025 - HIV medication company Gilead Sciences Inc (Nasdaq: GILD) reported on Monday that it has presented new data at IAS 2025 from its Phase 3 PURPOSE trials, confirming the efficacy and tole...
14 July 2025 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) announced on Monday that it has submitted an application to the US Food and Drug Administration (FDA) to expand the approved use...
14 July 2025 - Imugene Limited (ASX: IMU), an Australia-based, clinical-stage immuno-oncology company, announced on Monday new data from its Phase 1b clinical trial evaluating azer-cel (azercabtagene ...